A detailed history of Wambolt & Associates, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Wambolt & Associates, LLC holds 18,310 shares of JNJ stock, worth $2.65 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
18,310
Previous 18,009 1.67%
Holding current value
$2.65 Million
Previous $2.63 Million 12.73%
% of portfolio
0.81%
Previous 0.77%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$145.48 - $167.38 $43,789 - $50,381
301 Added 1.67%
18,310 $2.97 Million
Q2 2024

Aug 07, 2024

BUY
$144.38 - $157.78 $277,498 - $303,253
1,922 Added 11.95%
18,009 $2.63 Million
Q1 2024

Apr 30, 2024

BUY
$155.22 - $162.74 $220,257 - $230,928
1,419 Added 9.67%
16,087 $2.54 Million
Q4 2023

Feb 07, 2024

BUY
$145.6 - $158.88 $91,000 - $99,300
625 Added 4.45%
14,668 $2.3 Million
Q3 2023

Nov 06, 2023

BUY
$155.75 - $174.48 $66,349 - $74,328
426 Added 3.13%
14,043 $2.19 Million
Q2 2023

Aug 02, 2023

BUY
$154.35 - $166.11 $100,327 - $107,971
650 Added 5.01%
13,617 $2.25 Million
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $235,789 - $281,385
-1,561 Reduced 10.74%
12,967 $2.01 Million
Q4 2022

Jan 31, 2023

BUY
$160.2 - $179.79 $56,870 - $63,825
355 Added 2.5%
14,528 $2.57 Million
Q3 2022

Oct 18, 2022

BUY
$161.33 - $179.52 $12,745 - $14,182
79 Added 0.56%
14,173 $2.32 Million
Q2 2022

Aug 01, 2022

BUY
$168.19 - $186.01 $51,297 - $56,733
305 Added 2.21%
14,094 $2.5 Million
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $106,586 - $121,043
674 Added 5.14%
13,789 $2.46 Million
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $204,736 - $227,162
1,313 Added 11.13%
13,115 $2.24 Million
Q3 2021

Oct 20, 2021

BUY
$161.5 - $179.47 $243,865 - $270,999
1,510 Added 14.67%
11,802 $1.89 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $484,819 - $520,052
3,040 Added 41.92%
10,292 $1.71 Million
Q1 2021

Apr 19, 2021

BUY
$153.07 - $170.48 $186,439 - $207,644
1,218 Added 20.19%
7,252 $1.18 Million
Q4 2020

Jan 19, 2021

BUY
$137.11 - $157.38 $290,947 - $333,960
2,122 Added 54.24%
6,034 $950,000
Q3 2020

Nov 04, 2020

BUY
$140.38 - $153.83 $79,595 - $87,221
567 Added 16.95%
3,912 $582,000
Q2 2020

Jul 23, 2020

BUY
$128.81 - $155.51 $26,534 - $32,035
206 Added 6.56%
3,345 $470,000
Q1 2020

May 11, 2020

BUY
$111.14 - $153.99 $59,348 - $82,230
534 Added 20.5%
3,139 $412,000
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $64,770 - $74,391
508 Added 24.23%
2,605 $380,000
Q3 2019

Oct 15, 2019

BUY
$126.95 - $142.14 $126 - $142
1 Added 0.05%
2,097 $271,000
Q2 2019

Jul 26, 2019

BUY
$131.15 - $144.24 $35,541 - $39,089
271 Added 14.85%
2,096 $292,000
Q1 2019

Apr 11, 2019

SELL
$125.72 - $139.79 $5,280 - $5,871
-42 Reduced 2.25%
1,825 $247,000
Q4 2018

Jan 29, 2019

BUY
$122.84 - $147.84 $229,342 - $276,017
1,867 New
1,867 $241,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Wambolt & Associates, LLC Portfolio

Follow Wambolt & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wambolt & Associates, LLC with notifications on news.